ãã€ãªå»è¬åäŒæ¥ã§ãã Summit Therapeutics Inc. ã¯ãç±³åœãã©ãã³ã¢ã¡ãªã«ããšãŒãããã§ææçã®æ²»çè¬ãçºèŠãéçºãåååããŠããŸããå瀟ã¯ãã¯ãã¹ããªãã£ãªã€ãã¹ã»ãã£ãã£ã·ã«ææç (CDI) ã«éç¹ã眮ããèšåºããã°ã©ã ã宿œããŠããŸããå瀟ã®äž»å補ååè£ã¯ãCDI ã®æ²»çè¬ãšããŠç¬¬ III çžèšåºè©Šéšãè¡ãããŠããçµå£æäžã®äœååæçç©è³ªãªãžãã©ãŸãŒã«ã§ããå瀟ã¯ãŸããDiscuva ãã©ãããã©ãŒã ãéããŠæ·èã«ããææçãæ²»çãã DDS-01 ã·ãªãŒãºãããã³è
žå
现èç§ãæ²»çãã DDS-04 ã·ãªãŒãºãéçºããŠããŸããå瀟㯠2003 幎ã«èšç«ãããããµãã¥ãŒã»ããå·ã±ã³ããªããžã«æ ç¹ã眮ããŠããŸãã